Not Signed In -
Lactose Intolerance |
Lactose Intolerence |
Clinical Trial: Electrogastrography (EGC) in premature infants with feeding intolerance
This study has been completed.
|
Purpose
Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Infant, Newborn, Diseases | Drug: metoclopramide | Phase II |
MedlinePlus related topics: Infant and Toddler Health
Study Type: Interventional
Study Design: Treatment, Non-Randomized
Official Title: Electrogastrography (EGC) in premature infants with feeding intolerance: The effect of metoclopramide
Eligibility
Ages Eligible for Study: up to 1 Month, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Inclusion:
Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation
Location Information
Pennsylvania
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States
More Information
Study ID Numbers: NCRR-M01RR00240-1724
Record last reviewed: December 2003
Last Updated: October 13, 2004
Record first received: January 16, 2001
ClinicalTrials.gov Identifier: NCT00008736
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: December 2003
Last Updated: October 13, 2004
Record first received: January 16, 2001
ClinicalTrials.gov Identifier: NCT00008736
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
